Sabra Health Care REIT, Inc. (NASDAQ: SBRA – Get a rating) received a consensus rating of “Hold” by the twelve rating agencies that currently cover the stock, market beat reports. Seven equity research analysts rated the stock with a hold recommendation and five gave the company a buy recommendation. The 12-month average price target among brokers who have covered the stock over the past year is $15.85.
A number of brokerages have recently released reports on SBRA. Capital One Financial began covering Sabra Health Care REIT in a research note on Friday, June 3. They set an “equal weight” rating and a price target of $15.50 on the stock. Jefferies Financial Group downgraded Sabra Health Care REIT from a buy rating to a hold rating and reduced its target price for the stock from $15.00 to $14.00 in a Thursday research note June 30th. Mizuho upgraded Sabra Health Care REIT from a “neutral” rating to a “buy” rating and reduced its target price for the stock from $16.00 to $15.00 in a Wednesday, May 25 research note. StockNews.com began covering Sabra Health Care REIT in a research note on Thursday, March 31. They issued a “holding” rating on the stock. Finally, Credit Suisse Group raised its price target on Sabra Health Care REIT from $14.00 to $15.00 and gave the stock a “neutral” rating in a Monday, April 4 research note.
Sabra Health Care REIT Stock up 0.6%
Shares of NASDAQ: SBRA opened at $14.74 on Friday. The stock’s 50-day moving average price is $14.00 and its 200-day moving average price is $13.62. Sabra Health Care REIT has a 12-month low of $11.44 and a 12-month high of $19.01. The stock has a market capitalization of $3.40 billion, a P/E ratio of -30.08 and a beta of 1.33. The company has a current ratio of 3.60, a quick ratio of 3.60 and a debt ratio of 0.70.
Sabra Health Care REIT (NASDAQ: SBRA – Get a rating) last reported quarterly earnings data on Wednesday, May 4. The real estate investment trust reported earnings per share (EPS) of $0.18 for the quarter, beating consensus analyst estimates of $0.17 by $0.01. Sabra Health Care REIT posted a negative return on equity of 3.15% and a negative net margin of 18.28%. During the same quarter of the previous year, the company achieved EPS of $0.39. On average, stock analysts expect Sabra Health Care REIT to post 1.47 earnings per share for the current year.
Sabra Health Care REIT announces dividend
The company also recently disclosed a quarterly dividend, which was paid on Tuesday, May 31. Shareholders of record on Monday, May 16 received a dividend of $0.30. The ex-dividend date was Friday, May 13. This represents an annualized dividend of $1.20 and a yield of 8.14%. Sabra Health Care REIT’s dividend payout ratio (DPR) is currently -244.89%.
Sabra Health Care REIT Institutional Negotiation
Institutional investors and hedge funds have recently been buying and selling stocks. Vanguard Group Inc. increased its holdings of Sabra Health Care REIT shares by 2.4% in the first quarter. Vanguard Group Inc. now owns 36,317,289 shares of the real estate investment trust worth $540,765,000 after purchasing an additional 859,548 shares in the last quarter. Principal Financial Group Inc. increased its equity stake in Sabra Health Care REIT by 1.5% during the first quarter. Principal Financial Group Inc. now owns 17,124,112 shares of the real estate investment trust worth $254,977,000 after purchasing an additional 256,869 shares in the last quarter. State Street Corp increased its holdings of Sabra Health Care REIT shares 18.1% in the first quarter. State Street Corp now owns 12,035,766 shares of the real estate investment trust valued at $179,213,000 after buying an additional 1,840,939 shares in the last quarter. Centersquare Investment Management LLC increased its position in shares of Sabra Health Care REIT by 23.3% during the fourth quarter. Centersquare Investment Management LLC now owns 7,289,224 shares of the real estate investment trust worth $98,695,000 after acquiring an additional 1,377,573 shares in the last quarter. Finally, Goldman Sachs Group Inc. increased its position in shares of Sabra Health Care REIT by 7.5% during the first quarter. Goldman Sachs Group Inc. now owns 5,486,951 shares of the real estate investment trust valued at $81,701,000 after acquiring 384,092 additional shares last quarter. 91.61% of the shares are currently held by hedge funds and other institutional investors.
Sabra Health Care REIT Company Profile
As of March 31, 2022, Sabra’s investment portfolio included 416 properties held for investment. These include (i) 279 skilled nursing/transitional care facilities, (ii) 59 senior housing communities (senior residences – leased), (iii) 50 senior housing communities operated by third-party property managers pursuant to property management agreements (retirement homes – managed), (iv) 13 behavioral health facilities and (v) 15 specialty hospitals and other facilities), an asset held for sale, an investment in a lease-purchase, 16 investments in loans receivable (including (i) two mortgage loans, (ii) a construction loan and (iii) 13 other loans), seven investments in preferred shares and an investment in a unconsolidated joint venture.
Recommended Stories
Get news and reviews for Sabra Health Care REIT Daily – Enter your email address below to receive a concise daily summary of breaking news and analyst ratings for Sabra Health Care REIT and related companies with MarketBeat.com’s free daily email newsletter.